REBECCA SHAFFER: Open Payments
NPI 1487418125 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$671 in 21 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $520 · 2025 $671
Food & beverage: $572Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $223 |
| Exeltis, USA Inc. | 7 | $184 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $130 |
| SHIELD THERAPEUTICS INC | 2 | $40 |
| Biogen, Inc. | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| PFIZER INC. | 1 | $18 |
| MILLICENT US INC | 1 | $14 |
Products named: Veozah, TWIRLA, ANNOVERA, SLYND, ACCRUFER, ZURZUVAE, Mirena, ABRYSVO.
Industry payments across AR — which companies pay providers there.
